Fundz

seragy holding GmbH raises €12M in funding to accelerate the development of its SeRAS platform.

PRIVATEOct 14, 2026

Amount Raised

€12 Million

Round Type

Venture

HanoverBiotechnologyHealth CareGeneticsTherapeutics

Investors

State of Lower SaxonyMittelständische BeteiligungsgesellschaftCommerzbank

Description

seragy holding GmbH, based in Hanover, Germany, has raised €12M to accelerate the development of its biomarker strategy platform focused on neurodegenerative diseases. The funding will also help expand its laboratory and analytical capabilities and grow its team. Key backers included Commerzbank, MBG, and the State of Lower Saxony.

Quick answer

seragy holding GmbH raised €12 Million in a funding round, dated October 14, 2026. Investors: State of Lower Saxony, Mittelständische Beteiligungsgesellschaft and Commerzbank. seragy holding GmbH is based in Hanover, Lower Saxony, Germany.

How much did seragy holding GmbH raise?
seragy holding GmbH raised €12 Million in a funding round on October 14, 2026.
Who invested in seragy holding GmbH?
State of Lower Saxony, Mittelständische Beteiligungsgesellschaft and Commerzbank are named as investors in this round.
What does seragy holding GmbH do?
seragy holding GmbH is a provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies.
Where is seragy holding GmbH based and how big is it?
seragy holding GmbH is based in Hanover, Lower Saxony, Germany.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as seragy holding GmbH that raised within 45 days of this round, from Fundz verified event records.

  • VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
  • Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
  • Aptadir Therapeutics raised $45M (Seed) on September 29, 2026.
  • Typewriter Therapeutics raised $56M (Series A) on September 2, 2026.
  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.

Who to call at seragy holding GmbH, and when

A new round usually means seragy holding GmbH is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day seragy holding GmbH raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at seragy holding GmbH, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at seragy holding GmbH. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

seragy holding GmbH

Location

Hanover, Lower Saxony, Germany

About

seragy holding GmbH is a provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies. The company develops quantitative translational biomarkers for conditions such as Alzheimer’s, Parkinson’s, and ALS. Their platform, SeRAS, utilizes advanced techniques to generate molecular fingerprints from patient samples to characterize protein aggregation patterns.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment seragy holding GmbH raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for seragy holding GmbH's next move

See what Strategic adds

seragy holding GmbH raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.